Argenx Se (ARGX) Assets Growth (1y) (2016 - 2026)
Argenx Se (ARGX) Assets Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.81% |
| Dec 31, 2025 | 39.99% |
| Jun 30, 2025 | 49.60% |
| Dec 31, 2024 | 36.55% |
| Jun 30, 2024 | 50.18% |
| Dec 31, 2023 | 44.93% |
| Jun 30, 2023 | -1.71% |
| Dec 31, 2022 | 9.96% |
| Jun 30, 2022 | 1.13% |
| Dec 31, 2021 | 28.69% |
| Jun 30, 2021 | 44.23% |
| Dec 31, 2020 | 39.61% |
| Jun 30, 2020 | 96.46% |
| Dec 31, 2019 | 140.29% |
| Jun 30, 2019 | 163.91% |
| Dec 31, 2018 | 51.18% |
| Jun 30, 2018 | 110.67% |
| Dec 31, 2017 | 282.40% |
| Dec 31, 2016 | 126.69% |